Evaluation of prevalence's of pfdhfr and pfdhps mutations in Angola
2011

Prevalence of Drug Resistance Mutations in Malaria in Angola

Sample size: 452 publication Evidence: high

Author Information

Author(s): Fortes Filomeno, Dimbu Rafael, Figueiredo Paula, Neto Zoraima, do Rosário Virgílio E, Lopes Dinora

Primary Institution: Programa Nacional de Controlo da Malária/Ministério da Saúde de Angola

Hypothesis

What is the prevalence of pfdhfr and pfdhps mutations associated with Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in Angola?

Conclusion

The study indicates that the implementation of intermittent preventive treatment using sulfadoxine/pyrimethamine in children needs to be reviewed due to high mutation frequencies associated with resistance.

Supporting Evidence

  • 90.3% of samples carried the mutation 51I in the pfdhfr gene.
  • 99.1% of isolates harbored the mutant allele 108N in the pfdhfr gene.
  • 83.1% of samples were mutant type 437G in the pfdhps gene.
  • Only 25% of isolates had the triple pfdhfr mutation.
  • High frequencies of mutations indicate potential for treatment failure.

Takeaway

This study looked at how many malaria parasites in Angola have changed to resist a common treatment. It found a lot of these changes, which means the treatment might not work well anymore.

Methodology

Blood samples were collected from children under five in five provinces, and mutations were detected using PCR RFLP.

Limitations

The study only included asymptomatic children and may not represent the entire population.

Participant Demographics

Children under five years of age from five provinces in Angola.

Digital Object Identifier (DOI)

10.1186/1475-2875-10-22

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication